Top Feed
$50 million suit against crypto ‘godfather’ reads like a movie plot, featuring corrupt LA deputies
Iza-Bren EGFR×HER3 bispecific ADC at ESMO 2025: Phase III BL-B01D1-303 results in metastatic nasopharyngeal carcinoma
He Was a Teen Tech Prodigy. Then He Became the ‘Crypto Godfather’
Bispecific ADC Iza-Bren Leads to Improved ORR Vs Chemo in Nasopharyngeal Cancer
ESMO 2025 – iza-bren’s US backing comes with toxicity | ApexOnco - Clinical Trials news and analysis
SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration
SystImmune Announces iza-bren Meets One of the Dual Primary Endpoints in the BL-B01D1-303 Trial in Recurrent or Metastatic NPC Patients with Results Presented as a Late-Breaking Oral Presentation at ESMO
Pharmaceutical research and development pipeline
Hafiz Manzoor RA k Namaz e Janaze Se Pehly Hazratji ka Kaam Karne Walon ko Aham Nasihat V#bayan
Frontline Iza-Bren Plus Osimertinib Elicits 100% ORR in EGFR-Mutant NSCLC
Key Takeaways · Iza-bren plus osimertinib achieved a 100% objective response rate in EGFR-mutated NSCLC, with a confirmed ORR of 95% at a 2.5 mg...
$50 million suit against crypto ‘godfather’ reads like a movie plot, featuring corrupt LA deputies
Deputies served as henchmen for Adam Iza, targeting an event planner who had crossed him. They stole his money, trashed his house and framed...
Iza-Bren EGFR×HER3 bispecific ADC at ESMO 2025: Phase III BL-B01D1-303 results in metastatic nasopharyngeal carcinoma
Iza-Bren, an EGFR×HER3 bispecific ADC, is designed to co-target two relevant receptors in NPC biology and deliver a cytotoxic payload to tumor...
Hafiz Manzoor RA k Namaz e Janaze Se Pehly Hazratji ka Kaam Karne Walon ko Aham Nasihat V#bayan
حافظ منظور صاحب رح کے نمازِ جنازہ سے پہلے حضرت جی رابع مولانا محمد سعد صاحب کی کام کرنے والوں کو اہم نصیحت #hafizmanzoor ...
He Was a Teen Tech Prodigy. Then He Became the ‘Crypto Godfather’
Adam Iza built the crypto trading platform Zort. Then he fell in with hackers and started a criminal conspiracy including extortion schemes...
Bispecific ADC Iza-Bren Leads to Improved ORR Vs Chemo in Nasopharyngeal Cancer
Key Takeaways · Iza-bren showed a significantly higher ORR of 54.6% compared to 27.0% with chemotherapy in recurrent/metastatic NPC patients.
ESMO 2025 – iza-bren’s US backing comes with toxicity | ApexOnco - Clinical Trials news and analysis
Bristol stated that “haematologic adverse events were effectively managed by standard medical measures”. The trial, described as iza-bren's...
SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration
"Together with Bristol Myers Squibb, we have made significant progress in developing iza-bren globally. We remain deeply committed to delivering...
SystImmune Announces iza-bren Meets One of the Dual Primary Endpoints in the BL-B01D1-303 Trial in Recurrent or Metastatic NPC Patients with Results Presented as a Late-Breaking Oral Presentation at ESMO
SystImmune, in collaboration with BMS outside of China, is developing iza-bren (BL-B01D1), a bispecific antibody-drug conjugate (ADC) that...
Pharmaceutical research and development pipeline
Our pipeline is focused on research in therapeutic areas where we can accelerate the development of transformational, life-changing medicines for patients.
Stats
46190
Rank
6.3K
Points
1
Videos
11
Articles
0
Reviews
0
Comments
Profile
Tags
Groups
This member is not part of any groups yet.